Protein interaction disruption in cancer.

Our results show the utility of our method both in identifying disruptions of protein interactions from known ligand binding site mutations, and in selecting novel clinically significant interactions. Supporting website with software and data: https://www.cs.cmu.edu/~mruffalo/mut-edge-disrupt/ .